University of California, Los Angeles About Us   |   Diversity and Inclusion  |   Contact Us   |   Campus Directory   |   Giving   |   Maps/Directions
Shaping the Future

Karol Watson, M.D.

Contact Information:

Work Phone Number:

(310) 794-7121
(310) 825-8811

Office Address:

Office Address
A7-118B CHS
Los Angeles, CA
UNITED STATES

Work Email Address:

kwatson@mednet.ucla.edu

Website:

  

Home Page:

     Web-Profile


Associate Professor, Department of Medicine

Endocrinology, Diabetes and Hypertension


Awards and Honors:

UCLA School of Medicine
UCLA School of Medicine
UCLA School of Medicine

Publications:

Perreault Leigh, Pan Qing, Mather Kieren J, Watson Karol E, Hamman Richard F, Kahn Steven E, Kahn Steven E   Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study Lancet, 2012; 379(9833): 2243-51.
Delahanty Linda M, Pan Qing, Jablonski Kathleen A, Watson Karol E, McCaffery Jeanne M, Shuldiner Alan, Kahn Steven E, Knowler William C, Florez Jose C, Franks Paul W, Franks Paul W   Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program Diabetes care, 2012; 35(2): 363-6.
Van Hee Victor C, Szpiro Adam A, Prineas Ronald, Neyer Jonathan, Watson Karol, Siscovick David, Kyun Park Sung, Kaufman Joel D   Association of long-term air pollution with ventricular conduction and repolarization abnormalities Epidemiology (Cambridge, Mass.), 2011; 22(6): 773-80.
Kim Catherine, Diez-Roux Ana V, Nettleton Jennifer A, Polak Joseph F, Post Wendy S, Siscovick David S, Watson Karol E, Vahratian Anjel M   Sex differences in subclinical atherosclerosis by race/ethnicity in the multi-ethnic study of atherosclerosis American journal of epidemiology, 2011; 174(2): 165-72.
Mitchell Judith E, Ferdinand Keith C, Watson Karol E, Wenger Nanette K, Watkins Laurence O, Flack John M, Gavin James R, Reed James W, Saunders Elijah, Wright Jackson T   Treatment of heart failure in African Americans--a call to action Journal of the National Medical Association, 2011; 103(2): 86-98.
Huang Chiang-Ching, Liu Kiang, Pope Richard M, Du Pan, Lin Simon, Rajamannan Nalini M, Huang Qi-Quan, Jafari Nadereh, Burke Gregory L, Post Wendy, Watson Karol E, Johnson Craig, Daviglus Martha L, Lloyd-Jones Donald M   Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis PloS one, 2011; 6(6): e21067.
Jain Aditya, McClelland Robyn L, Polak Joseph F, Shea Steven, Burke Gregory L, Bild Diane E, Watson Karol E, Budoff Matthew J, Liu Kiang, Post Wendy S, Folsom Aaron R, Lima Joćo A C, Bluemke David A   Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the multi-ethnic study of atherosclerosis (MESA) Circulation. Cardiovascular imaging, 2011; 4(1): 8-15.
Sanchez Daniel R, Diez Roux Ana V, Michos Erin D, Blumenthal Roger S, Schreiner Pamela J, Burke Gregory L, Watson Karol   Comparison of the racial/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis The American journal of cardiology, 2011; 107(1): 41-6.
Mair Christina, Diez Roux Ana V, Osypuk Theresa L, Rapp Stephen R, Seeman Teresa, Watson Karol E   Is neighborhood racial/ethnic composition associated with depressive symptoms? The multi-ethnic study of atherosclerosis Social science & medicine (1982), 2010; 71(3): 541-50.
Hajat Anjum, Diez-Roux Ana, Franklin Tracy G, Seeman Teresa, Shrager Sandi, Ranjit Nalini, Castro Cecilia, Watson Karol, Sanchez Brisa, Kirschbaum Clemens   Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis Psychoneuroendocrinology, 2010; 35(6): 932-43.
Kershaw Kiarri N, Diez Roux Ana V, Carnethon Mercedes, Darwin Christine, Goff David C, Post Wendy, Schreiner Pamela J, Watson Karol   Geographic variation in hypertension prevalence among blacks and whites: the multi-ethnic study of atherosclerosis American journal of hypertension, 2010; 23(1): 46-53.
Barr R Graham, Bluemke David A, Ahmed Firas S, Carr J Jeffery, Enright Paul L, Hoffman Eric A, Jiang Rui, Kawut Steven M, Kronmal Richard A, Lima Joćo A C, Shahar Eyal, Smith Lewis J, Watson Karol E   Percent emphysema, airflow obstruction, and impaired left ventricular filling The New England journal of medicine, 2010; 362(3): 217-27.
Watson Karol E   Pitavastatin: the newest HMG-CoA reductase inhibitor Reviews in cardiovascular medicine, 2010; 11(1): 26-32.
Meadows Telly A, Bhatt Deepak L, Hirsch Alan T, Creager Mark A, Califf Robert M, Ohman E Magnus, Cannon Christopher P, Eagle Kim A, Alberts Mark J, Goto Shinya, Smith Sidney C, Wilson Peter W F, Watson Karol E, Steg P Gabriel, Steg P Gabriel   Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry American heart journal, 2009; 158(6): 1038-45.
Ferdinand Keith C, Flack John M, Saunders Elijah, Victor Ronald, Watson Karol, Kursun Attila, Jamieson Michael J, Shi Harry   Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus Journal of clinical hypertension (Greenwich, Conn.), 2009; 11(10): 585-93.
Ranjit Nalini, Diez-Roux Ana V, Sanchez Brisa, Seeman Teresa, Shea Steven, Shrager Sandi, Watson Karol   Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis Psychosomatic medicine, 2009; 71(7): 748-55.
Gallo Linda C, de Los Monteros Karla Espinosa, Allison Matthew, Diez Roux Ana, Polak Joseph F, Watson Karol E, Morales Leo S   Do socioeconomic gradients in subclinical atherosclerosis vary according to acculturation level? Analyses of Mexican-Americans in the multi-ethnic study of atherosclerosis Psychosomatic medicine, 2009; 71(7): 756-62.
Fonarow Gregg C, Deedwania Prakash, Fonseca Vivian, Nesto Richard W, Watson Karol, Tarka Elizabeth, Lukas Mary Ann, Madan Anuradha, Shabbout Mayadah   Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial Journal of the American Society of Hypertension : JASH, 2009; 3(3): 210-20.
McMahon Maureen, Grossman Jennifer, Skaggs Brian, Fitzgerald John, Sahakian Lori, Ragavendra Nagesh, Charles-Schoeman Christina, Watson Karol, Wong Weng Kee, Volkmann Elizabeth, Chen Weiling, Gorn Alan, Karpouzas George, Weisman Michael, Wallace Daniel J, Hahn Bevra H   Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus Arthritis and rheumatism, 2009; 60(8): 2428-37.
Watson Karol E   The JUPITER trial: How will it change clinical practice? Reviews in cardiovascular medicine, 2009; 10(2): 91-6.
Friedman Allon N, Friedman Allon, Marrero David, Ma Yong, Ackermann Ronald, Narayan K M Venkat, Barrett-Connor Elizabeth, Watson Karol, Knowler William C, Horton Edward S, Horton Edward S   Value of urinary albumin-to-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals Diabetes care, 2008; 31(12): 2344-8.
Cziraky Mark J, Watson Karol E, Talbert Robert L   Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting Journal of managed care pharmacy : JMCP, 2008; 14(8 Suppl): S3-28; quiz S30-1.
Folsom Aaron R, Kronmal Richard A, Detrano Robert C, O'Leary Daniel H, Bild Diane E, Bluemke David A, Budoff Matthew J, Liu Kiang, Shea Steven, Szklo Moyses, Tracy Russell P, Watson Karol E, Burke Gregory L   Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA) Archives of internal medicine, 2008; 168(12): 1333-9.
Burke Gregory L, Bertoni Alain G, Shea Steven, Tracy Russell, Watson Karol E, Blumenthal Roger S, Chung Hyoju, Carnethon Mercedes R   The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis Archives of internal medicine, 2008; 168(9): 928-35.
Detrano Robert, Guerci Alan D, Carr J Jeffrey, Bild Diane E, Burke Gregory, Folsom Aaron R, Liu Kiang, Shea Steven, Szklo Moyses, Bluemke David A, O'Leary Daniel H, Tracy Russell, Watson Karol, Wong Nathan D, Kronmal Richard A   Coronary calcium as a predictor of coronary events in four racial or ethnic groups The New England journal of medicine, 2008; 358(13): 1336-45.
Watson Karol E   What is the evidence in favor of low-dose statin therapy in 2008? Current atherosclerosis reports, 2008; 10(1): 33-8.
Watson Karol E   Cardiovascular risk reduction among African Americans: a call to action Journal of the National Medical Association, 2008; 100(1): 18-26.
Flack John M, Victor Ronald, Watson Karol, Ferdinand Keith C, Saunders Elijah, Tarasenko Lisa, Jamieson Michael J, Shi Harry, Bruschi Pia   Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial Mayo Clinic proceedings. Mayo Clinic, 2008; 83(1): 35-45.
Watson Karol, Fung Constance H, Budoff Matthew   Quality indicators for the care of ischemic heart disease in vulnerable elders Journal of the American Geriatrics Society, 2007; 55 Suppl 2(1): S366-72.
Gorkin Janet U, Watson Karol, Knopp Robert H   Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia The Journal of family practice, 2007; 56(8 Suppl Strategies): S1-7; quiz S8.
Watson Karol E, Ansell Benjamin J, Watson Andrew D, Fonarow Gregg C   HDL function as a target of lipid-modifying therapy Reviews in cardiovascular medicine, 2007; 8(1): 1-8.
Watson Karol   Managing cardiometabolic risk: an evolving approach to patient care Critical pathways in cardiology, 2007; 6(1): 5-14.
Fonarow Gregg C, Watson Karol E   New insights into understanding cardiometabolic risk. Introduction Reviews in cardiovascular medicine, 2007; 8 Suppl 4(12 Suppl 2): S1-2.
Watson Karol E   Novel therapies for cardiometabolic risk reduction and implications for clinical practice Reviews in cardiovascular medicine, 2007; 8 Suppl 4(12 Suppl 2): S37-42.
Watson Karol E   Pathogenesis of CHD: the role of elevated triglycerides Journal of the American Academy of Nurse Practitioners, 2007; 19(12 Suppl 2): 4-6, 13-4.
Watson Karol E   Lowering levels of lipids and homocysteine Reviews in cardiovascular medicine, 2006; 7(4): 248-50.
Watson Karol   Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension Current cardiology reports, 2006; 8(6): 433-8.
Polk Donna M, Watson Karol   Hospital discharge treatments after an acute event: evidence for a systems approach to prevention Coronary artery disease, 2006; 17(3): 239-41.
Watson Karol E   Air pollution and heart disease Reviews in cardiovascular medicine, 2006; 7(1): 44.
Ansell Benjamin J, Watson Karol E, Fogelman Alan M, Navab Mohamad, Fonarow Gregg C   High-density lipoprotein function recent advances Journal of the American College of Cardiology, 2005; 46(10): 1792-8.
Watson Karol   Guidelines for prevention of CVD in women The Journal of family practice, 2005; Suppl(10): 7-8.
Watson Karol E, Fonarow Gregg C   The past, present, and future of statin therapy Reviews in cardiovascular medicine, 2005; 6(3): 129-39.
Watson Karol E   Novel serum markers for risk prediction in acute coronary syndromes Reviews in cardiovascular medicine, 2005; 6(1): 59-60.
Mosca Lori, Merz Noel Bairey, Blumenthal Roger S, Cziraky Mark J, Fabunmi Rosalind P, Sarawate Chaitanya, Watson Karol E, Willey Vincent J, Stanek Eric J   Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting Circulation, 2005; 111(4): 488-93.
Ansell Benjamin J, Navab Mohamad, Watson Karol E, Fonarow Gregg C, Fogelman Alan M   Anti-inflammatory properties of HDL Reviews in endocrine & metabolic disorders, 2004; 5(4): 351-8.
Krantz Mori J, Leeman-Castillo Bonnie A, Watson Karol E, Mehler Philip S   Coronary heart disease care in older women: optimizing diagnostic and therapeutic decisions Journal of the American Medical Women's Association (1972), 2004; 59(4): 286-94.
Watson Karol E, Fonarow Gregg C   Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap Reviews in cardiovascular medicine, 2004; 5 Suppl 3(6): S42-4.
Watson Karol E   Cardiovascular disease in African Americans. Introduction Reviews in cardiovascular medicine, 2004; 5 Suppl 3(6): S1-2.
Fonarow Gregg C, Watson Karol E   High-density lipoprotein cholesterol as a therapeutic target to reduce cardiovascular events American heart journal, 2004; 147(6): 939-41.
Watson Karol E, Topol Eric J   Pathobiology of atherosclerosis: are there racial and ethnic differences? Reviews in cardiovascular medicine, 2004; 5 Suppl 3(6): S14-21.
Watson Karol E   The relationship between inflammation and atherosclerotic events Reviews in cardiovascular medicine, 2004; 5(1): 66-8.
Watson Karol E, Peters Harmel Anne L, Matson Gary   Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance Journal of cardiovascular pharmacology and therapeutics, 2003; 8(4): 253-60.
Hall W Dallas, Clark Luther T, Wenger Nanette K, Wright Jackson T, Kumanyika Shiriki K, Watson Karol, Horton Ella W, Flack John M, Ferdinand Keith C, Gavin James R, Reed James W, Saunders Elijah, O'Neal Welton   For the patient. What is the Metabolic Syndrome and why is it important? Ethnicity & disease, 2003; 13(4): 546.
Watson Karol E, Horowitz Barbara N, Matson Gary   Lipid abnormalities in insulin resistant states Reviews in cardiovascular medicine, 2003; 4(4): 228-36.
Tintut Yin, Alfonso Zeni, Saini Trishal, Radcliff Kristen, Watson Karol, Boström Kristina, Demer Linda L   Multilineage potential of cells from the artery wall Circulation, 2003; 108(20): 2505-10.
Watson Karol E   Plasma lipoprotein concentrations in ethnic populations Current cardiology reports, 2003; 5(6): 483-7.
Hall W Dallas, Clark Luther T, Wenger Nanette K, Wright Jackson T, Kumanyika Shiriki K, Watson Karol, Horton Ella W, Flack John M, Ferdinand Keith C, Gavin James R, Reed James W, Saunders Elijah, O'Neal Welton, O'Neal Welton   The Metabolic Syndrome in African Americans: a review Ethnicity & disease, 2003; 13(4): 414-28.
Fonarow Gregg C, Watson Karol E   Effective strategies for long-term statin use The American journal of cardiology, 2003; 92(1A): 27i-34i.
Watson Karol E, Fonarow Gregg C   Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice Clinical cornerstone, 2003; Suppl 1(2): S11-7.
Watson Karol, Jamerson Kenneth   Therapeutic lifestyle changes for hypertension and cardiovascular risk reduction Journal of clinical hypertension (Greenwich, Conn.), 2003; 5(1 Suppl 1): 32-7.
Ansell Benjamin J, Watson Karol E, Weiss Robert E, Fonarow Gregg C   hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation Heart disease (Hagerstown, Md.), 2003; 5(1): 2-7.
UCLA    |    Terms & Conditions    |    Disability Resources    |    UC Regents